Catalyst Funds Management Pty LTD Abb Vie Inc. Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,200 shares of ABBV stock, worth $242,496. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,200
Previous 10,500
88.57%
Holding current value
$242,496
Previous $2.07 Billion
89.72%
% of portfolio
0.05%
Previous 0.46%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
4,095Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.5 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.02 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $357B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...